Guardant Health Inc [NASDAQ: GH] jumped around 2.29 points on Thursday, while shares priced at $49.94 at the close of the session, up 4.81%.
Compared to the average trading volume of 2.10M shares, GH reached a trading volume of 3240647 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Guardant Health Inc [GH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GH shares is $46.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GH stock is a recommendation set at 1.44. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for Guardant Health Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on January 23, 2025. The new note on the price target was released on June 28, 2024, representing the official price target for Guardant Health Inc stock. Previously, the target price had yet another raise to $32, while Jefferies analysts kept a Buy rating on GH stock.
The Average True Range (ATR) for Guardant Health Inc is set at 2.46, with the Price to Sales ratio for GH stock in the period of the last 12 months amounting to 8.91.
How has GH stock performed recently?
Guardant Health Inc [GH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.76. With this latest performance, GH shares gained by 64.06% in over the last four-week period, additionally plugging by 37.61% over the last 6 months – not to mention a rise of 116.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GH stock in for the last two-week period is set at 78.21, with the RSI for the last a single of trading hit 80.58, and the three-weeks RSI is set at 75.65 for Guardant Health Inc [GH]. The present Moving Average for the last 50 days of trading for this stock 36.28, while it was recorded at 48.01 for the last single week of trading, and 28.31 for the last 200 days.
Guardant Health Inc [GH]: Deeper insight into the fundamentals
Guardant Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.85 and a Current Ratio set at 6.22.
Earnings analysis for Guardant Health Inc [GH]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Guardant Health Inc go to 16.87%.
Insider trade positions for Guardant Health Inc [GH]
There are presently around $105.29%, or 110.44%% of GH stock, in the hands of institutional investors. The top three institutional holders of GH stocks are: VANGUARD GROUP INC with ownership of 11.64 million shares, which is approximately 9.5609%. BLACKROCK INC., holding 11.24 million shares of the stock with an approximate value of $$324.55 million in GH stocks shares; and BLACKROCK INC., currently with $$175.97 million in GH stock with ownership which is approximately 5.0063%.
